The pathogenesis of acne

Acta Dermatovenerologica Croatica

Volumn 13, Issue 1, 2005, Pages 44-49

  Knor, Tanja ^a  

^a UNIVERSITY OF SARAJEVO   (Bosnia and Herzegovina)

Author keywords

Acne vulgaris; Pathogenesis

Indexed keywords

CD1 ANTIGEN; CD14 ANTIGEN; CHEMOTACTIC FACTOR; CYTOKINE; EPIDERMAL GROWTH FACTOR; GAMMA INTERFERON; HYALURONIDASE; ICOSANOID; INTERLEUKIN 1; INTERLEUKIN 12; INTERLEUKIN 8; LEUKOTRIENE B4; LIPID; PROTEINASE; REACTIVE OXYGEN METABOLITE; RETINOID; TETRACYCLINE DERIVATIVE; TOLL LIKE RECEPTOR; TRANSFORMING GROWTH FACTOR ALPHA; TRIACYLGLYCEROL LIPASE; TUMOR NECROSIS FACTOR ALPHA; ANTIINFECTIVE AGENT;

ACNE VULGARIS; CELLULAR IMMUNITY; COMPLEMENT ACTIVATION; CYTOKINE PRODUCTION; DARIER DISEASE; HUMAN; HUMORAL IMMUNITY; IMMUNE RESPONSE; INFLAMMATION; KERATINOCYTE; PATHOGENESIS; PROPIONIBACTERIUM ACNES; REVIEW; RISK FACTOR; SEBUM; SEBUM SECRETION; ARTICLE; IMMUNOLOGY; METABOLISM; MICROBIOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY;

ACNE VULGARIS; ANTI-BACTERIAL AGENTS; HUMANS; INFLAMMATION; KERATINOCYTES; PROPIONIBACTERIUM ACNES; SEBUM;

EID: 20344362665     PISSN: 1330027X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (41)

1. Aldana OL, Holland DB, Cunliffe WJ. Variation in pilosebaceous duct keratinocyte proliferation in acne patients. Dermatology 1998;196:98-99.
2. Cunliffe WJ, Holland DB, Clark SM, Stables Gl. Comedogenesis: some new aetiological, clinical and therapeutic strategies. Br J Dermatol 2000;142:1084-91.
3. Bataille V, Snieder H, MacGregor AJ, Sasieni P, Spector TD. The influence of genetics and environmental factors in the pathogenesis of acne: a twin study of acne in women. J Invest Dermatol 2002;119:1317-22.
4. Thiboutot D, Bayne E, Thorne J, Gilliland K, Flanagan J, Shao Q, et al. Immunolocalization of 5α-reductase isozymes in acne lesions and normal skin. Arch Dermatol 2000;136:1125-9.
5. Burkhart CN, Gottwald L. Assessment of etiologic agents in acne pathogenesis. Skinmed 2003;2:222-8.
6. Zouboulis CC, Seltmann H, Hiroi N, Chen WC, Young M, Oeff M, et al. Corticotropin-relasing hormone: an autocrine hormone that promotes lipogenesis in human sebocytes. Proc Natl Acad Sci USA 2002;99:7148-53.
7. Lee DJ, Van Dyke GS, Kim J. Update on pathogenesis and treatment of acne. Curr Opin Pediatr 2003;15:405-10.
8. Toyoda M, Morohashi M. New aspects in acne inflammation. Dermatology 2003;206:17-23.
9. Dréno B, Khammari A. Acne - inflammatory affection of pilosebaceus follicle: the most frequent cutaneous illness of moderne time. In: European PharmacoTherapy 2003 - September 2003. London: Business briefing Ltd; 2003. p. 130-5 Available at: http//www.bbriefings.com/index.cfm/Healthcare & Pharmaceutical. Accessed: February 6, 2004.
10. Fulton JE Jr. The sebaceous follicle. In: Fulton JE Jr, ed. Acne Rx. Tustin: Fulton JE; 2001. p 33-5.
11. Burkhart CN. Clinical assessment of acne pathogenesis with treatment implications. Int Pediatr 2003;18:14-9.
12. Gollnick H. Current concepts of the pathogenesis of acne: implications for drug treatment. Drugs 2003;63:1579-96.
13. Thiboutot D, Knaggs H, Gilliland K, Hagari S. Activity of type 1 5α-reductase is greater in the follicular infrainfundibulum compared with the epidermis. Br J Dermatol 1997;136:166-71.
14. Brown SK, Shalita AR. Acne vulgaris. Lancet 1998;351:1871-6.
15. Cunliffe WJ. A pocket guide to acne. London: Science Press Limited; 1989.
16. Koreck A, Pivarcsi A, Dobozy A, Kemény L. The role of innate immunology in the pathogenesis of acne. Dermatology 2003;206:96-105.
17. Guy R, Kealey T. Modelling the infundibulum in acne. Dermatology 1998;196:32-7.
18. Burkhart CG, Burkhart CN, Lehmann PF. Acne: a review of immunologic and microbiologic factors. Postgrad Med J 1999;75:328-31.
19. Burkhart CG, Burkhart CN. Propionibacterium acnes: an indigenous bacterium may be pathogenic in several cutaneous disease states. Arch Dermatol 2001;137:1250.
20. Akamatsu H, Niwa Y, Matsunaga K. Effect of palmitic acid on neutrophil functions in vitro. Int J Dermatol 2001;40:640-3.
21. Jain A, Basal E. Inhibition of Propionibacterium acnes-induced mediators of inflammation by Indian herbs. Phytomedicine 2003;10:34-8.
22. Walters CE, Ingham E, Eady EA, Cove JH, Kearney JN, Cunliffe WJ. In vitro modulation of keratinocyte-derived interleukin-1 alpha (IL-1 alpha) and peripheral blood mononuclear cell-derived IL-1 beta release in response to cutaneous commensal microorganisms. Infect Immun 1995;63:1223-8.
23. Liu L, Roberts AA, Ganz T. By IL-1 signaling, monocyte-derived cells dramatically enhance the epidermal antimicrobial response to lipopolysaccharide. J Immunol 2003;170:575-80.
24. th Congress of the European Academy of Dermatology, Barcelona, October 15-18, 2003. Book of abstracts. J Eur Acad Dermatol Venereol 2003;17(Suppl 3)21.
25. Eady EA, Cove JH. Is acne an infection of blocked pilosebaceous follicles? Implications for antimicrobial treatment. Am J Clin Dermatol 2000;1:201-9.
26. Downie MM, Sanders DA, Kealey T. Modelling the remission of individual acne lesions in vitro. Br J Dermatol 2002;147:869-78.
27. Vowels BR, Yang S, Leyden JJ. Induction of proinflammatory cytokines by a soluble factor of Propionibacterium acnes: implications for chronic inflammatory acne. Infect Immun 1995;63:3158-65.
28. Kersey P, Sussman M, Dahl M. Delayed skin test reactivity to Propionibacterium acnes correlates with severity of inflammation in acne vulgaris. Br J Dermatol 1980;103:651-5.
29. Medzhitov R, Janeway C Jr. Innate immunity. N Engl J Med 2000;343:338-44.
30. Murphy JE, Robert C, Kupper TS. Interleukin-1 and cutaneous inflammation: a crucial link between innate and acquired immunity. J Invest Dermatol 2000;114:602-8.
31. Kim J, Ochoa MT, Krutzik SR, Takeuchi O, Uematsu S, Legaspi AJ, et al. Activation of toll-like receptor 2 in acne triggers inflammatory cytokine responses. J Immunol 2002;169:1535-41.
32. Medzhitov R, Preston-Hurlburt P, Janeway CA Jr. A human homologue of the Drosophila toll protein signals activation of adaptive immunity. Nature 1997;388:394-7.
33. Nickoloff BJ. In This Issue. J Invest Dermatol 2003;121: v-vi.
34. Chen Q, Koga T, Uchi H, Hara H, Terao H, Moroi Y, et al. Propionibacterium acnes-induced IL-8 production may be mediated by NF-kappaB activation in human monocytes. J Dermatol Sci 2002;29:97-103.
35. Zouboulis CC, Nestoris S, Adler YD, Orth M, Orfanos CE, Picardo M, et al A new concept for acne therapy: a pilot study with zileuton, an oral 5-lipoxygenase inhibitor. Arch Dermatol 2003;139:668-70.
36. Kang S, Voorhes JJ. Photoaging therapy with topical tretinoin: an evidence-based analysis. J Am Acad Dermatol 1998;39:55-61.
37. Shapiro SS, Latriano L. Pharmacokinetic and pharmacodynamic considerations of retinoids: tretinoin. J Am Acad Dermatol 1998;39:13-6.
38. Tortora G, Ciardiello F. cAMP-dependent protein konase A and retinoids: functional interactions and therapeutic implications. Retinoids 1999;15:142-4.
39. Kang S. Current perspectives on acne inflammation and scarring. Proceedings of the 20th World Congress of Dermatology, Paris, July 1-5, 2002.
40. Fisher GJ, Talwar HS, Lin J, Lin P, McPhillips F, Wang ZQ, et al. Retinoic acid inhibits induction of c-Jun protein by ultraviolet radiation that occurs subsequent to activation of mitogen-activated protein kinase pathways in human skin in vivo. J Clin Invest 1998;101:1432-40.
41. Fisher GJ, Datta S, Wang ZQ, Li XY, Quan T, Chung JH, et al. c-Jun-dependent inhibition of cutaneous procollagen transcription following ultraviolet irradiation is reversed by all - transretinoic acid. J Clin Invest 2000;106:663-70.